COVID-19 vaccines for patients with haematological conditions
Publication date: Available online 31 March 2021Source: The Lancet HaematologyAuthor(s): Clare Sun, Christopher Pleyer, Adrian Wiestner (Source: The Lancet Haematology)
Source: The Lancet Haematology - April 1, 2021 Category: Hematology Source Type: research
47th Annual Meeting of the EBMT
Publication date: Available online 31 March 2021Source: The Lancet HaematologyAuthor(s): Yaiza del Pozo Martín (Source: The Lancet Haematology)
Source: The Lancet Haematology - April 1, 2021 Category: Hematology Source Type: research
Building an understanding of transgender care
Publication date: April 2021Source: The Lancet Haematology, Volume 8, Issue 4Author(s): The Lancet Haematology (Source: The Lancet Haematology)
Source: The Lancet Haematology - March 24, 2021 Category: Hematology Source Type: research
2 + 2 in the long term: informing a new standard of care in 2021 for early stage, unfavourable Hodgkin lymphoma
Publication date: April 2021Source: The Lancet Haematology, Volume 8, Issue 4Author(s): Nicole Wong Doo, Judith Trotman (Source: The Lancet Haematology)
Source: The Lancet Haematology - March 24, 2021 Category: Hematology Source Type: research
Looking long-term: an unmet need in immune thrombocytopenia
Publication date: April 2021Source: The Lancet Haematology, Volume 8, Issue 4Author(s): Cindy Neunert (Source: The Lancet Haematology)
Source: The Lancet Haematology - March 24, 2021 Category: Hematology Source Type: research
Model solutions for ethical allocation during cancer medicine shortages
Publication date: April 2021Source: The Lancet Haematology, Volume 8, Issue 4Author(s): Andrew Hantel, Jeff Peppercorn, Gregory A Abel (Source: The Lancet Haematology)
Source: The Lancet Haematology - March 24, 2021 Category: Hematology Source Type: research
Correction to Lancet Haematol 2020; 7: e112–21
Publication date: April 2021Source: The Lancet Haematology, Volume 8, Issue 4Author(s): (Source: The Lancet Haematology)
Source: The Lancet Haematology - March 24, 2021 Category: Hematology Source Type: research
Correction to Lancet Haematol 2021: 8: e254–66
Publication date: April 2021Source: The Lancet Haematology, Volume 8, Issue 4Author(s): (Source: The Lancet Haematology)
Source: The Lancet Haematology - March 24, 2021 Category: Hematology Source Type: research
Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14)
Publication date: April 2021Source: The Lancet Haematology, Volume 8, Issue 4Author(s): Sarah Gillessen, Annette Plütschow, Michael Fuchs, Jana Markova, Richard Greil, Max S Topp, Julia Meissner, Josée M Zijlstra, Dennis A Eichenauer, Paul J Bröckelmann, Volker Diehl, Peter Borchmann, Andreas Engert, Bastian von Tresckow (Source: The Lancet Haematology)
Source: The Lancet Haematology - March 24, 2021 Category: Hematology Source Type: research
Dexamethasone plus oseltamivir versus dexamethasone in treatment-naive primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial
Publication date: April 2021Source: The Lancet Haematology, Volume 8, Issue 4Author(s): Lu Sun, Juan Wang, Linlin Shao, Chenglu Yuan, Hongguo Zhao, Daqi Li, Zhencheng Wang, Panpan Han, Yafei Yu, Miao Xu, Hongyu Zhao, Jihua Qiu, Hai Zhou, Xinguang Liu, Yu Hou, Jun Peng, Ming Hou (Source: The Lancet Haematology)
Source: The Lancet Haematology - March 24, 2021 Category: Hematology Source Type: research
Quality of control groups in randomised trials of multiple myeloma enrolling in the USA: a systematic review
Publication date: April 2021Source: The Lancet Haematology, Volume 8, Issue 4Author(s): Ghulam Rehman Mohyuddin, Kelly Koehn, Douglas Sborov, Brian McClune, Al-Ola Abdallah, Aaron M Goodman, Vinay Prasad (Source: The Lancet Haematology)
Source: The Lancet Haematology - March 24, 2021 Category: Hematology Source Type: research
Factor B inhibition for paroxysmal nocturnal haemoglobinuria
Publication date: Available online 23 March 2021Source: The Lancet HaematologyAuthor(s): Robert A Brodsky (Source: The Lancet Haematology)
Source: The Lancet Haematology - March 23, 2021 Category: Hematology Source Type: research
Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2, proof-of-concept trial
Publication date: Available online 23 March 2021Source: The Lancet HaematologyAuthor(s): Antonio M Risitano, Alexander Röth, Juliette Soret, Camilla Frieri, Flore Sicre de Fontbrune, Luana Marano, Ferras Alashkar, Lina Benajiba, Serena Marotta, Izabela Rozenberg, Julie Milojevic, Peter End, Prasanna K Nidamarthy, Guido Junge, Régis Peffault de Latour (Source: The Lancet Haematology)
Source: The Lancet Haematology - March 23, 2021 Category: Hematology Source Type: research
Late toxicities in non-Hodgkin lymphoma: extended follow-up matters
Publication date: Available online 2 March 2021Source: The Lancet HaematologyAuthor(s): Gita Thanarajasingam, Karin E Smedby, Ann LaCasce (Source: The Lancet Haematology)
Source: The Lancet Haematology - March 3, 2021 Category: Hematology Source Type: research
Rituximab plus high-dose chemotherapy (MegaCHOEP) or conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma: 10-year follow-up of a randomised, open-label, phase 3 trial
Publication date: Available online 2 March 2021Source: The Lancet HaematologyAuthor(s): Fabian Frontzek, Marita Ziepert, Maike Nickelsen, Bettina Altmann, Bertram Glass, Mathias Haenel, Lorenz Truemper, Gerhard Held, Martin Bentz, Peter Borchmann, Martin Dreyling, Andreas Viardot, Frank P Kroschinsky, Bernd Metzner, Annette M Staiger, Heike Horn, German Ott, Andreas Rosenwald, Markus Loeffler, Georg Lenz (Source: The Lancet Haematology)
Source: The Lancet Haematology - March 3, 2021 Category: Hematology Source Type: research
